A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066. (2017)
Attributed to:
Restricted Diversity; Constrained Diversity-Oriented Synthesis
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2017.04.037
PubMed Identifier: 28495381
Publication URI: http://europepmc.org/abstract/MED/28495381
Type: Journal Article/Review
Volume: 25
Parent Publication: Bioorganic & medicinal chemistry
Issue: 13
ISSN: 0968-0896